A Phase I, Randomized, Placebo-Controlled, Double Blind, Trial of Safety, Tolerabilityand Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis.

Trial Profile

A Phase I, Randomized, Placebo-Controlled, Double Blind, Trial of Safety, Tolerabilityand Efficacy Study of Topical AKP-11 Administration to Participants with Arthritis.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Feb 2017

At a glance

  • Drugs AKP 11 (Primary)
  • Indications Gout; Rheumatoid arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Akaal Pharma
  • Most Recent Events

    • 09 Feb 2017 Status changed from recruiting to completed.
    • 15 Aug 2016 Status changed from not yet recruiting to recruiting.
    • 15 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top